Siemens Healthineers to restructure diagnostics division

Published On 2022-11-11 08:00 GMT   |   Update On 2022-11-11 08:00 GMT

Berlin: Siemens Healthineers is to restructure its diagnostics division in the hope of making around 300 million euros ($301.71 million) in savings by 2025, the U.S.-German medical device maker said upon announcing its fiscal 2022 results on Wednesday.One-off costs are initially expected in order to achieve the savings, the Siemens subsidiary said.Sources from within the company said...

Login or Register to read the full article

Berlin: Siemens Healthineers is to restructure its diagnostics division in the hope of making around 300 million euros ($301.71 million) in savings by 2025, the U.S.-German medical device maker said upon announcing its fiscal 2022 results on Wednesday.

One-off costs are initially expected in order to achieve the savings, the Siemens subsidiary said.
Sources from within the company said the restructuring will involve cutting jobs and abandoning certain locations.
Siemens Healthineers also said it was lowering its targets for the laboratory division, with comparable sales growth of 3-5 percent per year until 2025, rather than 4-6 percent previously. The adjusted return on sales before interest and taxes (EBIT margin) is seen at 8-12 percent by 2025 instead of a previously hoped-for 15 percent.
The group said it was targeting adjusted basic earnings per share of between 2 euros and 2.20 euros for fiscal 2023.
During fiscal 2022, it achieved comparable revenue growth of 5.9 percent at around 21.7 billion euros, with full-year adjusted earnings before interest and taxes (EBIT) of 3.7 billion euros.
Both were slightly above analysts' forecasts according to a consensus provided on the company's website.

Read also: Siemens Healthineers launches new production line of CT Scanners in Bengaluru

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News